ABCA1 and metabolic dysfunction-associated steatotic liver disease: Our results supported the notion that circRNA_0001805 exerts a protective effect against NAFLD by interacting with miR-106a-5p/miR-320a, thus restoring the decreased expression of ABCA1/CPT1 and inhibiting NF-κB signaling.